Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A third of patients treated with Opdivo plus Yervoy experienced complete or partial tumor remission.
Tecentriq plus Avastin improved improved overall survival and patient experiences during treatment.
Immunotherapy did not improve overall survival but led to fewer side effects and better quality of life.
Between August 2018 and January 2019, the FDA doubled the number of liver cancer treatments.
With the approval of Cyramza, there are now five targeted therapies for hepatocellular carcinoma.
Adding internal radiation or TACE did appear to help certain people, however.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.